Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Blue Heron Biotechnology
company
About
Blue Heron Biotechnology provides a range of synthetic DNA sequences and related services to researchers and biotechnology companies.
- 11 - 50
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $3.68M
- Industries
- Biotechnology,Genetics,Health Care
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Blue Heron Biotechnology has been a pioneer and leader of the gene synthesis market since its founding in 1999. Blue Heron provides the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries, including 19 of the top 20 pharmaceutical and biotechnology companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.68M
Blue Heron Biotechnology has raised a total of
$3.68M
in funding over 2 rounds. Their latest funding was raised on
Jan 16, 2007 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 16, 2007 | Series D | $3.68M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Blue Heron Biotechnology is funded by 1 investors.
Crabtree Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
